$TMDX is facing scrutiny following a short-seller report from Scorpion Fund, which has been described as incendiary and lacking substantiation. Analysts and investors are discussing the implications of this report, with some expressing skepticism regarding its claims. In response to the allegations, $TMDX has publicly addressed what it calls inaccurate and misleading assertions made by Scorpion Fund. Meanwhile, $BPMC has seen a notable increase in stock value, rising approximately 16% recently, buoyed by positive analyst notes and significant interest from long investors. Several market participants have highlighted their confidence in $BPMC, with expectations of substantial returns and potential acquisition premiums. As both stocks navigate through these developments, the market remains attentive to further updates and performance metrics.